- Sciwind has two Western partners for its obesity drug, but is open to moreSciwind Biosciences has already licensed its GLP-1 obesity drug ecnoglutide twice over — to Pfizer and Verdiva Bio — but it is not done yet. The Chinese biotech is seeking new partners for the righ…Endpoints · 1mo ago↗ source
- Opinion: I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule“American science is too valuable to be turned into a political football,” writes David J. Skorton, president of the Association of American Medical Colleges.STAT · 1mo ago↗ source
- Opinion: Ebola outbreak response requires engaging with religious traditions and leaders“Failing to engage religious and traditional leaders in meaningful ways was a grave misstep in previous Ebola outbreaks,” researchers write.